Perspectives on Inhibiting β‐Amyloid Aggregation through Structure‐Based Drug Design
- 24 July 2015
- journal article
- review article
- Published by Wiley in ChemMedChem
- Vol. 10 (9) , 1467-1474
Abstract
Targeting β‐amyloid (Aβ) remains the most desired strategy in Alzheimer’s disease (AD) drug discovery research. Many peptides that specifically target Aβ aggregates are known, encompassing efforts from both industrial and academic research settings. However, in clinical terms, not much success has been gained with peptide research; in turn, small drug‐like molecules are already globally recognized as showing promise as an alternate approach. Aβ aggregation inhibitors are the most important part of the multifunctional drug design regimen for treating AD. Unfortunately, rational drug design approaches with small molecules are still in the initial stages. Herein we highlight, update, and elaborate on the structural anatomy of Aβ and known Aβ aggregation inhibitors in hopes of helping to optimize their use in structure‐based drug design approaches toward inhibitors with greater specificity. Furthermore, we present the first review of efforts to target a previously uncharacterized region of acetylcholinesterase: the N‐terminal 7–20 sub‐region, which was experimentally elucidated to participate in Aβ aggregation and deposition.Keywords
This publication has 142 references indexed in Scilit:
- A Key Role for Lysine Residues in Amyloid β-Protein Folding, Assembly, and ToxicityACS Chemical Neuroscience, 2012
- Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid ProteinsJournal of the American Chemical Society, 2011
- Structurally distinct toxicity inhibitors bind at common loci on β‐amyloid fibrilProtein Science, 2010
- Structural Differences between Aβ(1-40) Intermediate Oligomers and Fibrils Elucidated by Proteolytic Fragmentation and Hydrogen/Deuterium ExchangeBiophysical Journal, 2009
- Structure and Dynamics of the Aβ21–30 Peptide from the Interplay of NMR Experiments and Molecular SimulationsJournal of the American Chemical Society, 2008
- Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse modelNature Medicine, 2006
- Inhibitors of Amyloid Toxicity Based on β-sheet Packing of Aβ40 and Aβ42Biochemistry, 2006
- Molecular structure of amyloid fibrils: insights from solid-state NMRQuarterly Reviews of Biophysics, 2006
- Experimental Constraints on Quaternary Structure in Alzheimer's β-Amyloid FibrilsBiochemistry, 2005
- Structural Role of Glycine in Amyloid Fibrils Formed from Transmembrane α-HelicesBiochemistry, 2005